PlainRecalls
FDA Drug Moderate Class II Ongoing

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3

Reported: June 1, 2022 Initiated: May 6, 2022 #D-0889-2022

Product Description

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3

Reason for Recall

Defective Delivery System: customer complaints exceeded respective action limits.

Details

Recalling Firm
Noven Pharmaceuticals Inc
Units Affected
274, 110 patches
Distribution
Nationwide to the U.S. Market
Location
Miami, FL

Frequently Asked Questions

What product was recalled?
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3. Recalled by Noven Pharmaceuticals Inc. Units affected: 274, 110 patches.
Why was this product recalled?
Defective Delivery System: customer complaints exceeded respective action limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 1, 2022. Severity: Moderate. Recall number: D-0889-2022.